NGS-characterized tissue for oncology research
Source FFPE tissue and TMAs from TriStar’s oncology repository, selected against the molecular and clinical criteria for your study. Start with existing characterization and add NGS when further variant data are needed.
THE INTEGRATED SERVICES APPROACH
Samples, services and pathology expertise through one partner
Repository samples
Selected for your study
- Fewer handoffs
- Spend less time coordinating samples and additional work across providers.
- Pathology-informed decisions
- Connect tissue suitability, assay selection and interpretation.
- Coordinated sample use
- Plan tissue allocation and laboratory work together, with one point of contact.
CHARACTERIZED TISSUE
Molecular findings with the specimen behind them
NSCLC with Oncomine and PD-L1 characterization
Bring molecular and protein-level findings into the same tissue selection. This NSCLC collection includes adenocarcinoma and squamous cell carcinoma with histopathology, PD-L1 status and Oncomine Precision Assay NGS data.
- Molecular data
- Oncomine Precision Assay
- Protein biomarker
- PD-L1, clone 22C3
- Clinical context
- Histopathology; follow-up data optional
TISSUE MICROARRAYS
Molecularly characterized tissue microarrays
Explore tissue microarrays (TMAs) with existing molecular characterization. Review additional molecular and clinical criteria against your study requirements.
NSCLC
Adenocarcinoma and squamous cell carcinoma with histopathology and optional follow-up data.
Post-treatment NSCLC
Post-treatment tissue with mutation information and follow-up data.
Ovarian cancer
Multiple ovarian histologies with follow-up data; BRCA information is available for a subset.
Colorectal cancer
BRAF-characterized groups with histopathology information.
ADDITIONAL NGS
Extend the molecular profile of selected tissue
Add sequencing to your repository request to investigate the genes and variants relevant to your study.
- SNVs
- Single-nucleotide variants
- CNVs
- Copy-number changes
- Indels
- Insertions and deletions
- Fusions
- Gene rearrangements
Variant coverage depends on the selected assay and available tissue. Explore existing FFPE molecular characterization before defining additional sequencing requirements.
Work with our experienced scientific team to tailor biospecimens, data, and integrated services to your research needs.
Our approach begins with our customers’ science.
We focus our acquisition on patient cohorts that meet the needs of biopharma, clinical, and translational researchers.
Plan your study
Find tissue for your NGS study
Tell us your indication, molecular criteria, cohort size and preferred tissue format. We’ll review relevant repository specimens and existing data, with additional NGS scoped if your study needs it.